Twelve years of the Spanish acromegaly registry: a historical view of acromegaly management in Spain

Endocrinologia y Nutricion

Volumn 57, Issue 2, 2010, Pages 39-42

  Sesmilo, Gemma ^a   M Webb, Susan ^b  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; OCTREOTIDE; PASIREOTIDE; PEGVISOMANT;

ACROMEGALY; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG HALF LIFE; HUMAN; IMMUNORADIOMETRIC ASSAY; RADIOIMMUNOASSAY; REGISTER; SPAIN;

ACROMEGALY; ADENOMA; COMBINED MODALITY THERAPY; COMORBIDITY; CRANIAL IRRADIATION; DATA COLLECTION; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMAN GROWTH HORMONE; HUMANS; HYPOPHYSECTOMY; PEPTIDES, CYCLIC; PITUITARY NEOPLASMS; RECEPTORS, SOMATOSTATIN; REGISTRIES; RETROSPECTIVE STUDIES; SOMATOSTATIN; SPAIN;

EID: 77949654749     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2010.01.003     Document Type: Article

References (24)

1. Etxabe J., Gaztambide S., Latorre P., and Vázquez J.A. Acromegaly: an epidemiological study. J Endocrinol Invest 16 (1993) 181-187
2. Mestrón A., Webb S.M., Astorga R., Benito P., Catalá M., Gaztambide S., et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151 (2004) 439-446
3. Costa A.C., Rossi A., Martinelli Jr. C.E., Machado H.R., and Moreira A.C. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?. J Clin Endocrinol Metab 87 (2002) 3142-3147
4. Giustina A., Barkan A., Casanueva F.F., Cavagnini F., Frohman L., Ho K., et al. S. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85 (2000) 526-529
5. S. Melmed A., Colao A., Barkan M., Molitch A.B., Grossman D., Kleinberg D., et al. Guidelines for Acromegaly Management: An Update. J Clin Endocrinol Metab 94 (2009) 1507
6. Trainer P.J., Drake W.M., Katznelson L., Freda P.U., Herman-Bonert V., van der Lely A.J., et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342 (2000) 1171-1177
7. Johnson M.R., Chowdrey H.S., Thomas F., Grint C., and Lightman S.L. Pharmacokinetics and efficacy of the long-acting somatostatin analogue somatuline in acromegaly. Eur J Endocrinol 130 (1994) 229-234
8. Hunter S.J., Shaw J.A., Lee K.O., Wood P.J., Atkinson A.B., and Bevan J.S. Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretion. Clin Endocrinol (Oxf) 50 (1999) 245-251
9. Caron P., Bex M., Cullen D.R., Feldt-Rasmussen U., Picó Alfonso A.M., Pynka S., et al. One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel. Clin Endocrinol (Oxf) 60 (2004) 734-740
10. Biermasz N.R., van den Oever N.C., Frölich M., Arias A.M., Smit J.W., Romijn J.A., et al. Sandostatin LAR in acromegaly: a 6-week injection interval suppresses GH secretion as effectively as a 4-week interval. Clin Endocrinol (Oxf) 58 (2003) 288-295
11. Giustina A., Bonadonna S., Bugari G., Colao A., Cozzi R., Cannavo S., et al. High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. Eur J Endocrinol 161 (2009) 331-338
12. Ben-Shlomo A., and Melmed S. Pasireotide--a somatostatin analog for the potential treatment of acromegaly, neuroendocrine tumors and Cushing's disease. I Drugs 10 (2007) 885-895
13. Colao A., Ferone D., Cappabianca P., del Basso De Caro M.L., Marzullo P., et al. Effect of octreotide pretreatment on surgical outcome in acromegaly. J Clin Endocrinol Metab 82 (1997) 3308-3314
14. Losa M., Mortini P., Urbaz L., Ribotto P., Castrignano T., and Giovanelli M. Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates. J Neurosurg 104 (2006) 899-906
15. Biermasz N.R., Roelfsema F., Pereira A.M., and Romijn J.A. Cost-effectiveness of lanreotide Autogel in treatment algorithms of acromegaly. Expert Rev Pharmacoecon Outcomes Res 9 (2009) 223-234
16. Melmed S., Casanueva F.F., Cavagnini F., Chanson P., Frohman L., Grossman A., et al. Acromegaly Treatment Consensus Workshop Participants. Guidelines for acromegaly management. J Clin Endocrinol Metab 87 (2002) 4054-4058
17. Frank G., and Pasquini E. Endoscopic cavernous sinus surgery with special reference to pituitary adenomas. In: Laws E.R., and Sheehan J.P. (Eds). Pituitary surgery-a modern approach (2006), Karger, Basel, Switzerland 64-82
18. Fahlbusch R., Keller B., Ganslandt O., Kreutzer J., and Nimsky C. Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging. Eur J Endocrinol 153 (2005) 239-248
19. Bex M., Abs R., T'Sjoen G., Mockel J., Velkeniers B., Muermans K., et al. AcroBel--the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects. Eur J Endocrinol 157 (2007) 399-409
20. Mullan K., Sanabria C., Abram W.P., McConnell E.M., Courtney H.C., Hunter S.J., et al. Long term effect of external pituitary irradiation on IGF1 levels in patients with acromegaly free of adjunctive treatment. Eur J Endocrinol 161 (2009) 547-551
21. Jenkins P.J., Bates P., Carson M.N., Stewart P.M., and Wass J.A. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 91 (2006) 1239-1245
22. Minniti G., Jaffrain-Rea M.L., Osti M., Esposito V., Santoro A., Solda F., et al. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 62 (2005) 210-216
23. Attanasio R., Epaminonda P., Motti E., Giugni E., Ventrella L., Cozzi R., et al. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 88 (2003) 3105-3112
24. Castinetti F., Taieb D., Kuhn J.M., Chanson P., Tamura M., Jaquet P., et al. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab 90 (2005) 4483-4488